Clinical Trials · NCT00194792

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

TerminatedPhase 2Gonadorelin (Prohibited)
Phase
Phase 2
Recruitment status
Terminated
Sponsor
University of Washington
Enrollment
28
Start date
Aug 2005
Locations
1 site, United States
Primary endpoint
Number of Participants With Clinical Response
View Gonadorelin compound reference